Lucidicor Inc.

Neshanic Station, NJ · Biotech

PhosFluor, an engineered fluorescent protein biosensor that detects protein phosphorylation in real-time within living cells

Grants
$450K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel fluorescent biosensors to continuously visualize real-time protein phosphorylation in live cells$224,985
Federal grantDepartment of Health and Human Services · Phase I · Novel fluorescent biosensors to continuously visualize real-time protein phosphorylation in live cells$224,985
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3272ONCOC4, INC.—$50M
3273CLUE GENETICS INC.——
3274Ibex Investment Holdings LLC—$5.0M
3275Lucidicor Inc.——
3276DIVINER THERAPEUTICS, LLC——
3277VIROGENOMICS BIODEVELOPMENT, INC.——
3278ENZERNA BIOSCIENCES LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Fluorescent Protein Biosensor For Detection Of Kinase Activityapplication
  • Fluorescent Protein Biosensor For Detection Of Kinase Activityapplication
  • Fluorescent Protein Biosensor For Detection Of Kinase Activityapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.